Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.04 USD | -4.36% | -15.29% | +34.76% |
Mar. 21 | Fate Therapeutics, Inc. announced that it has received $19.996366 million in funding from Redmile Group, LLC | CI |
Mar. 19 | Fate Therapeutics Prices $100 Million Offering, Private Placement | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.76% | 574M | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.16% | 21.66B | |
-18.35% | 20.77B | |
-8.12% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Insider Trends: Fate Therapeutics Insider Disposition Interrupting 90-Day Buy Trend